Clinical Observation On Treatment Of Benign Paroxysmal Positional Vertigo Of Phlegm-turbid Upper Mongolian Type With Combined Reduction Of Zexi Decoction And Manipulation

Objective:This study first evaluated the clinical efficacy of Zexie Decoction plus flavor reduction combined with manipulative reduction in the treatment of otolithia(phlegm and turbid sputum type)through clinical observation.Followed by a 6-month follow-up of the patients,to observe the effect of the decoction of Alisma and manual reduction on the recurrence rate of the patients with turbid upper Mongolia type otolith vertigo after treatment,,so as to provide a clinical basis for the effective treatment of turbid upper Mongolia otolith according to.Methods: From May 1,2018 to July 31,2019,72 patients diagnosed as BPPV in the outpatient or inpatient department of Xianhu hospital,the First Affiliated Hospital of Guangxi University of traditional Chinese medicine were selected.72 patients were randomly divided into two groups according to the ratio of 1:1 by using the random number table method,36 of them each.According to different types of BPPV,the patients in both groups were treated with corresponding manual reduction as basic treatment.The treatment group was treated with Zexie Decoction twice a day,half an hour after meals;the observation group was treated with betahistine mesylate tablets three times a day,one tablet each time,after meals.The treatment course of both groups was 14 days.The changes of DHI scale score and TCM syndrome score before and after treatment were observed in the two groups,and the clinical efficacy of the patients after treatment was compared and evaluated.Then thepatients in the two groups were followed up for 6 months,and the number and number of relapses were counted.SPSS 22.0 was used for data processing.Results:1.Through statistical comparison,there was no significant difference between the two groups in general baseline such as gender,age,BPPV type,combined with basic diseases,and onset time(P > 0.05).There was no statistical significance(P > 0.05)between the two groups before treatment in all indicators such as vertigo disorder scale(DHI),vertigo TCM syndrome score,etc.2.Comparison of treatment efficiency: after 2 weeks of treatment,the total effective rate of the treatment group was 94.44%,and that of the observation group was 80.56%.The total effective rate of the treatment group was better than that of the observation group(P < 0.05),the difference was statistically significant.3.DHI scale comparison:after two weeks treatment,the total score of DHI scale in the treatment group was 9.33 ± 1.91,and that in the observation group was 13.50 ± 3.07.Both groups could improve the score of DHI scale,and the improvement effect in the treatment group was better than that in the observation group,the difference was statistically significant(P < 0.05).After treatment,the improvement of DHI-P,DHI-E and DHI-F in the treatment group was significantly higher than that in the observation group(P < 0.05).4.Comparison of TCM syndrome score: after 2 weeks,the total score of TCM syndrome score in the treatment group was 4.61 ± 1.53,and that in the observation group was 8.50 ± 1.90.The treatment of both groups could improve TCM syndrome,and the therapeutic effect in the treatment group was significantly higher than that in the observation group(P < 0.05),withstatistical significance.After treatment,the scores of dizziness,dizziness and visual rotation in the treatment group were lower than those in the observation group(P < 0.05),the difference was statistically significant.5.Comparison of recurrence rate: after 6-month follow-up,the recurrence rate of the treatment group was 2.78%,the number of recurrence was 1,and the number of recurrence was 1.The recurrence rate of the observation group was16.67%,and the number of recurrences was 6,including 4 recurrences once and 2 recurrences twice.The recurrence rate,the number of recurrences and the number of recurrences in the treatment group were significantly lower than those in the observation group(P < 0.05),which was statistically significant.Conclusions:1.The clinical symptoms of BPPV can be improved in the treatment group treated with modified Alisma decoction combined with manual reduction and the observation group treated with betahistine mesylate tablets combined with manual reduction.2.The clinical effect of Zexie decoction combined with manual reduction in the treatment of BPPV with turbid phlegm is better than that of betahistine mesylate combined with manual reduction in the observation group.3.The recurrence rate,the number of relapses and the number of relapses in the treatment group were lower than those in the observation group.4.There were no adverse events in the two groups during the test,and both groups were safe.